Literature DB >> 30485461

Bacteriophages: an overview of the control strategies against multiple bacterial infections in different fields.

Muhsin Jamal1, Sayed M A U S Bukhari1, Saadia Andleeb2, Muhammad Ali3, Sana Raza4, Muhammad A Nawaz5, Tahir Hussain1, Sadeeq U Rahman6, Syed S A Shah7.   

Abstract

Bacteriophages (phages/viruses) need host bacteria to replicate and propagate. Primarily, a bacteriophage contains a head/capsid to encapsidate the genetic material. Some phages contain tails. Phages encode endolysins to hydrolyze bacterial cell wall. The two main classes of phages are lytic or virulent and lysogenic or temperate. In comparison with antibiotics, to deal with bacterial infections, phage therapy is thought to be more effective. In 1921, the use of phages against bacterial infections was first demonstrated. Later on, in humans, phage therapy was used to treat skin infections caused by Pseudomonas species. Furthermore, phages were successfully employed against infections in animals - calves, lambs, and pigs infected with Escherichia coli. In agriculture, for instance, phages have successfully been used e.g., Apple blossom infection, caused by Erwinia amylovora, was effectively catered with the use of bacteriophages. Bacteriophages were also used to control E. coli, Salmonella, Listeria, and Campylobacter contamination in food. Comparatively, phage display is a recently discovered technology, whereby, bacteriophages play a significant role. This review is an effort to collect almost recent and relevant information regarding applications and complications associated with the use of bacteriophages.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  bacteriophage; endolysins; lysogenic; lytic; phage therapy

Mesh:

Substances:

Year:  2018        PMID: 30485461     DOI: 10.1002/jobm.201800412

Source DB:  PubMed          Journal:  J Basic Microbiol        ISSN: 0233-111X            Impact factor:   2.281


  14 in total

Review 1.  Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts.

Authors:  Sabrina Royer; Aléxia Pinheiro Morais; Deivid William da Fonseca Batistão
Journal:  Arch Microbiol       Date:  2021-01-20       Impact factor: 2.552

Review 2.  Battling Enteropathogenic Clostridia: Phage Therapy for Clostridioides difficile and Clostridium perfringens.

Authors:  Jennifer Venhorst; Jos M B M van der Vossen; Valeria Agamennone
Journal:  Front Microbiol       Date:  2022-06-13       Impact factor: 6.064

Review 3.  Effectiveness of Phage-Based Inhibition of Listeria monocytogenes in Food Products and Food Processing Environments.

Authors:  Iwona Kawacka; Agnieszka Olejnik-Schmidt; Marcin Schmidt; Anna Sip
Journal:  Microorganisms       Date:  2020-11-10

4.  Bacteriophages vB_Sen-TO17 and vB_Sen-E22, Newly Isolated Viruses from Chicken Feces, Specific for Several Salmonella enterica Strains.

Authors:  Katarzyna Kosznik-Kwaśnicka; Łukasz Grabowski; Michał Grabski; Mateusz Kaszubski; Marcin Górniak; Agata Jurczak-Kurek; Grzegorz Węgrzyn; Alicja Węgrzyn
Journal:  Int J Mol Sci       Date:  2020-11-21       Impact factor: 5.923

5.  Learning From Mistakes: The Role of Phages in Pandemics.

Authors:  Ahlam Alsaadi; Beatriz Beamud; Maheswaran Easwaran; Fatma Abdelrahman; Ayman El-Shibiny; Majed F Alghoribi; Pilar Domingo-Calap
Journal:  Front Microbiol       Date:  2021-03-17       Impact factor: 5.640

6.  Genomic Analysis of the First European Bacteriophages with Depolymerase Activity and Biocontrol Efficacy against the Phytopathogen Ralstonia solanacearum.

Authors:  Elena G Biosca; José Francisco Català-Senent; Àngela Figàs-Segura; Edson Bertolini; María M López; Belén Álvarez
Journal:  Viruses       Date:  2021-12-17       Impact factor: 5.048

7.  |Isolation and characterization of novel bacteriophages as a potential therapeutic option for Escherichia coli urinary tract infections.

Authors:  Edgar González-Villalobos; Rosa María Ribas-Aparicio; Gerardo Erbey Rodea Montealegre; Laura Belmont-Monroy; Yerisaidy Ortega-García; Gerardo Aparicio-Ozores; José Luis Balcázar; Carlos Alberto Eslava-Campos; Ulises Hernández-Chiñas; José Molina-López
Journal:  Appl Microbiol Biotechnol       Date:  2021-07-12       Impact factor: 4.813

8.  Characteristics of a Series of Three Bacteriophages Infecting Salmonella enterica Strains.

Authors:  Katarzyna Kosznik-Kwaśnicka; Karolina Ciemińska; Michał Grabski; Łukasz Grabowski; Marcin Górniak; Agata Jurczak-Kurek; Grzegorz Węgrzyn; Alicja Węgrzyn
Journal:  Int J Mol Sci       Date:  2020-08-26       Impact factor: 5.923

9.  In Vitro Evaluation of the Therapeutic Potential of Phage VA7 against Enterotoxigenic Bacteroides fragilis Infection.

Authors:  Nata Bakuradze; Maya Merabishvili; Khatuna Makalatia; Elene Kakabadze; Nino Grdzelishvili; Jeroen Wagemans; Cedric Lood; Irakli Chachua; Mario Vaneechoutte; Rob Lavigne; Jean-Paul Pirnay; Ivane Abiatari; Nina Chanishvili
Journal:  Viruses       Date:  2021-10-11       Impact factor: 5.048

10.  Construction of Leaderless-Bacteriocin-Producing Bacteriophage Targeting E. coli and Neighboring Gram-Positive Pathogens.

Authors:  Yoshimitsu Masuda; Shun Kawabata; Tatsuya Uedoi; Ken-Ichi Honjoh; Takahisa Miyamoto
Journal:  Microbiol Spectr       Date:  2021-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.